| A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives A Sezer, M Halilović-Alihodžić, AR Vanwieren, A Smajkan, A Karić, ... Journal of Genetic Engineering and Biotechnology 20 (1), 78, 2022 | 15 | 2022 |
| COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence A Hromić-Jahjefendić, A Sezer, AAA Aljabali, Á Serrano-Aroca, ... Biomedicines 11 (5), 1469, 2023 | 12 | 2023 |
| Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis E Bilajac, L Mahmutović, K Lundstrom, U Glamočlija, J Šutković, A Sezer, ... Viruses 14 (10), 2105, 2022 | 5 | 2022 |
| Polyphenol stability and bioavailability in cell culture medium: Challenges, limitations and future directions L Mahmutović, A Sezer, E Bilajac, A Hromić-Jahjefendić, VN Uversky, ... International Journal of Biological Macromolecules, 135232, 2024 | 3 | 2024 |
| Analysis of Antitumor Potential of Xanthene Compounds in Lymphoma Cells E Bilajac, U Glamočlija, A Osmanović, L Mahmutović, A Sezer, S Roca, ... Croatica Chemica Acta 96 (1), 59-68, 2023 | 2 | 2023 |
| The Intersection of Microbiome and Autoimmunity in Long COVID-19: Current Insights and Future Directions A Hromić-Jahjefendić, L Mahmutović, A Sezer, T Bećirević, ... Cytokine & Growth Factor Reviews, 2024 | | 2024 |
| In silico study of polyphenols as potential inhibitors of MALT1 protein in non-Hodgkin lymphoma A Sezer, L Mahmutović, B Akçeşme Medical Oncology 41 (1), 37, 2023 | | 2023 |
| Single and Combinatorial Effects of Metformin and Thymoquinone in Diffuse Large B Cell Lymphoma Cells U Glamočlija, L Mahmutovic, E Bilajac, V Šoljić, K Vukojević, A Sezer, ... Chemistry & Biodiversity, e202401533, 0 | | |